FORT WORTH, Texas — Galderma Laboratories has expanded its lineup of acne solutions with the introduction of Differin Daily Deep Cleanser and Differin Oil Control Moisturizer with SPF 30. The Nestlé Skin Health brand said Tuesday that both facial skin care products are rolling out to major retailers nationwide and online sellers starting this month at a
FORT WORTH, Texas — Galderma Laboratories L.P. has gained Food and Drug Administration approval for Differin Gel, an over-the-counter treatment for acne. Galderma said Friday that Differin Gel (adapalene gel 0.1%) is the first and only OTC acne product with a full prescription-strength retinoid, and the product represents the first new, FDA-approved active ingredient to
FORT WORTH, Texas — Cetaphil has unveiled a limited-edition product display at select CVS Pharmacy stores in partnership with the Children’s Skin Disease Foundation (CSDF) and its Camp Wonder initiative. The Galderma Laboratories skin care brand said Thursday that Cetaphil Moisturizing Cream (16 oz., $15.99) is being showcased at 1,500 CVS stores locations nationwide through
FORT WORTH — Galderma Laboratories L.P. has upgraded graphics and packaging for the Cetaphil product line. The redesign aims to provide a more simplified shopping experience at shelf, improved portfolio differentiation and clarity of product benefits. “The packaging upgrade of the Cetaphil portfolio signifies a new phase of growth for the brand as we continue
FORT WORTH, TEXAS — Galderma Laboratories L.P. is promoting its new over-the-counter acne treatment, Benzac Acne Solutions, with the company’s first-ever webisode series. Called “The Benzacs” and targeted at teens, the online series highlights Benzac Acne Solutions through 15-second Instagram videos and more than 80 images and short videos. Debuting on the @BenzacAcne Instagram handle, the
FORT WORTH, Texas — Galderma has made a series of executive appointments and announced a realignment of its North America business. The dermatology and skin care company said Thursday that Stuart Raetzman has been named as global chief executive officer of Galderma Pharma S.A. He reports to Humberto Antunes, chairman of Galderma Pharma S.A. and
